Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells

Redox Biology

Volumn 4, Issue , 2015, Pages 328-339

  Abdalla, Maher Y ^a,b   Ahmad, Iman M ^b   Switzer, Barbara ^a,b   Britigan, Bradley E ^a,b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

HO 1; Mycobacterium abscessus; Oxidative stress; THP 1 cells

Indexed keywords

BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; CATALASE; DICHLORODIHYDROFLUORESCEIN DIACETATE; FLUORESCENT DYE; GLUTATHIONE; HEME; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; HYDROETHIDINE; IRON; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PROTOPORPHYRIN TIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; METALLOPORPHYRIN; NFE2L2 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; PROTOPORPHYRIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELL FUSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; ENZYME RELEASE; ENZYME SYNTHESIS; FLUORESCENCE ANALYSIS; GLUTATHIONE METABOLISM; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; LYSOSOME; MACROPHAGE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NONHUMAN; OXIDATIVE STRESS; PHAGOSOME; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; THP 1 CELL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE ACTIVATION; MEMBRANE FUSION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MYCOBACTERIUM; PHYSIOLOGY; TUMOR CELL LINE;

MYCOBACTERIUM ABSCESSUS;

BILIRUBIN; BILIVERDINE; CELL LINE, TUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HOST-PATHOGEN INTERACTIONS; HUMANS; LYSOSOMES; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE FUSION; METALLOPORPHYRINS; MICROBIAL VIABILITY; MYCOBACTERIUM; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOSOMES; PROTEIN KINASE INHIBITORS; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 84921893150     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.01.012     Document Type: Article

References (62)

1. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2006, 114(5):319-328. http://www.ncbi.nlm.nih.gov/pubmed/16725007, 10.1111/j.1600-0463.2006.apm_390.x.
2. Griffith D.E., Girard W.M., Wallace R.J. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. American Review of Respiratory Disease 1993, 147(5):1271-1278. http://www.ncbi.nlm.nih.gov/pubmed/8484642, 10.1164/ajrccm/147.5.1271.
3. Chan E.D., Bai X., Kartalija M., Orme I.M., Ordway D.J. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease. American Journal of Respiratory Cell and Molecular Biology 2010, 43(4):387-393. http://www.ncbi.nlm.nih.gov/pubmed/20081053, 10.1165/rcmb.2009-0276TR.
4. Román A., Ussetti P., Solé A., Zurbano F., Borro J.M., Vaquero J.M., de Pablo A., Morales P., Blanco M., Bravo C., Cifrian J., de la Torre M., Gámez P., Laporta R., Monforte V., Mons R., Salvatierra A., Santos F., Solé J., Varela A. Guidelines for the selection of lung transplantation candidates. Archivos de Bronconeumologa 2011, 47(6):303-309. English Version. 10.1016/j.arbres.2011.03.007.
5. Bryant J.M., Grogono D.M., Greaves D., Foweraker J., Roddick I., Inns T., Reacher M., Haworth C.S., Curran M.D., Harris S.R., Peacock S.J., Parkhill J., Floto R.A. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 2013, 381(9877):1551-1560. http://www.ncbi.nlm.nih.gov/pubmed/23541540, 10.1016/S0140-6736(13)60632-7.
6. Abdalla M.Y., Mathahs M.M., Ahmad I.M. Protective role of heme oxygenase-1 in liver. Biologia 2012, 67(4):623-628. 10.2478/s11756-012-0058-1.
7. Abraham N.G., Lin J.H., Dunn M.W., Schwartzman M.L. Presence of heme oxygenase and NADPH cytochrome P-450 (c) reductase in human corneal epithelium. Investigative Ophthalmology & Visual Science 1987, 28(9):1464-1472. http://www.ncbi.nlm.nih.gov/pubmed/3114166.
8. Vile G.F., Tyrrell R.M. Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. Journal of Biological Chemistry 1993, 268(20):14678-14681. http://www.ncbi.nlm.nih.gov/pubmed/8325845.
9. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235(4792):1043-1046. http://www.ncbi.nlm.nih.gov/pubmed/3029864, 10.1126/science.3029864.
10. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiological Reviews 2006, 86(2):583-650. http://www.ncbi.nlm.nih.gov/pubmed/16601269, 10.1152/physrev.00011.2005.
11. Shan Y., Zheng J., Lambrecht R.W., Bonkovsky H.L. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 2007, 133(4):1166-1174. http://www.ncbi.nlm.nih.gov/pubmed/17919492, 10.1053/j.gastro.2007.08.002.
12. Abdalla M.Y., Ahmad I.M., Spitz D.R., Schmidt W.N., Britigan B.E. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. Journal of Medical Virology 2005, 76(4):489-497. http://www.ncbi.nlm.nih.gov/pubmed/15977232, 10.1002/jmv.20388.
13. Lee P.J., Alam J., Wiegand G.W., Choi A.M. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(19):10393-10398. http://www.ncbi.nlm.nih.gov/pubmed/8816811, 10.1073/pnas.93.19.10393.
14. Kocanova S., Buytaert E., Matroule J.-Y., Piette J., Golab J., de Witte P., Agostinis P. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 2007, 12(4):731-741. http://www.ncbi.nlm.nih.gov/pubmed/17219054, 10.1007/s10495-006-0016-x.
15. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. Journal of Experimental Medicine 2000, 192(7):1015-1026. http://www.ncbi.nlm.nih.gov/pubmed/11015442, 10.1084/jem.192.7.1015.
16. Busserolles J., Megías J., Terencio M.C., Alcaraz M.J. Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. International Journal of Biochemistry & Cell Biology 2006, 38(9):1510-1517. http://www.ncbi.nlm.nih.gov/pubmed/16697692, 10.1016/j.biocel.2006.03.013.
17. Lang D., Reuter S., Buzescu T., August C., Heidenreich S. Heme-induced heme oxygenase-1 (HO-1) in human monocytes inhibits apoptosis despite caspase-3 up-regulation. International Immunology 2005, 17(2):155-165. http://www.ncbi.nlm.nih.gov/pubmed/15611319, 10.1093/intimm/dxh196.
18. Rushworth S.A., MacEwan D.J. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood 2008, 111(7):3793-3801. http://www.ncbi.nlm.nih.gov/pubmed/18202225, 10.1182/blood-2007-07-104042.
19. Behar S.M., Martin C.J., Booty M.G., Nishimura T., Zhao X., Gan H.X., Divangahi M., Remold H.G. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunology 2011, 4(3):279-287. http://www.ncbi.nlm.nih.gov/pubmed/21307848, 10.1038/mi.2011.3.
20. Shiloh M.U., Manzanillo P., Cox J.S. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 2008, 3(5):323-330. http://www.ncbi.nlm.nih.gov/pubmed/18474359, 10.1016/j.chom.2008.03.007.
21. Kumar A., Deshane J.S., Crossman D.K., Bolisetty S., Yan B.S., Kramnik I., Agarwal A., Steyn A.J. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. Journal of Biological Chemistry 2008, 283(26):18032-18039. http://www.ncbi.nlm.nih.gov/pubmed/18400743, 10.1074/jbc.M802274200.
22. Zacharia V.M., Manzanillo P.S., Nair V.R., Marciano D.K., Kinch L.N., Grishin N.V., Cox J.S., Shiloh M.U. Cor, a novel carbon monoxide resistance gene, is essential for Mycobacterium tuberculosis pathogenesis. MBio 2013, 4(6). http://www.ncbi.nlm.nih.gov/pubmed/24255121, 10.1128/mBio.00721-13.
23. Olakanmi O., Britigan B.E., Schlesinger L.S. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infection and Immunity 2000, 68(10):5619-5627. http://www.ncbi.nlm.nih.gov/pubmed/10992462, 10.1128/IAI.68.10.5619-5627.2000.
24. Olakanmi O., Gunn J.S., Su S., Soni S., Hassett D.J., Britigan B.E. Gallium disrupts iron uptake by intracellular and extracellular Francisella Strains and exhibits therapeutic efficacy in a murine pulmonary infection model. Antimicrobial Agents and Chemotherapy 2010, 54(1):244-253. http://www.ncbi.nlm.nih.gov/pubmed/19917753, 10.1128/AAC.00655-09.
25. Shih R.-H., Yang C.-M. Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells. J. Neuroinflammation 2010, 7:86. http://www.ncbi.nlm.nih.gov/pubmed/21118574, 10.1186/1742-2094-7-86.
26. Cummins N.W., Weaver E.A., May S.M., Croatt A.J., Foreman O., Kennedy R.B., Poland G.A., Barry M.A., Nath K.A., Badley A.D. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. FASEB Journal 2012, 26(7):2911-2918. http://www.ncbi.nlm.nih.gov/pubmed/22490782, 10.1096/fj.11-190017.
27. Silva-Gomes S., Appelberg R., Larsen R., Soares M.P., Gomes M.S. Heme catabolism by heme oxygenase-1 confers host resistance to mycobacterium infection. Infection and Immunity 2013, 81(7):2536-2545. http://www.ncbi.nlm.nih.gov/pubmed/23630967, 10.1128/IAI.00251-13.
28. Abdalla M.Y., Britigan B.E., Wen F., Icardi M., McCormick M.L., LaBrecque D.R., Voigt M., Brown K.E., Schmidt W.N. Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C Core protein. Journal of Infectious Diseases 2004, 190(6):1109-1118. http://www.ncbi.nlm.nih.gov/pubmed/15319861, 10.1086/423488.
29. Yeligar S.M., Machida K., Kalra V.K. Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression. Journal of Biological Chemistry 2010, 285(46):35359-35373. http://www.ncbi.nlm.nih.gov/pubmed/20833713, 10.1074/jbc.M110.138636.
30. Alam J., Cook J.L. How many transcription factors does it take to turn on the heme oxygenase-1 Gene?. American Journal of Respiratory Cell and Molecular Biology 2007, 36(2):166-174. http://www.ncbi.nlm.nih.gov/pubmed/16990612, 10.1165/rcmb.2006-0340TR.
31. Kehrer J.P. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000, 149(1):43-50. http://www.ncbi.nlm.nih.gov/pubmed/10963860.
32. Gobin J., Moore C.H., Reeve J.R., Wong D.K., Gibson B.W., Horwitz M.A. Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins. Proceedings of the National Academy of Sciences 1995, 92(11):5189-5193. http://www.ncbi.nlm.nih.gov/pubmed/7761471, 10.1073/pnas.92.11.5189.
33. Antunes L.C., Imperi F., Minandri F., Visca P. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 2012, 56(11):5961-5970. http://www.ncbi.nlm.nih.gov/pubmed/22964249, 10.1128/AAC.01519-12.
34. Olakanmi O., Kesavalu B., Pasula R., Abdalla M.Y., Schlesinger L.S., Britigan B.E. Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes. Antimicrobial Agents and Chemotherapy 2013, 57(12):6074-6080. http://www.ncbi.nlm.nih.gov/pubmed/24060870, 10.1128/AAC.01543-13.
35. Zhu Z., Wilson A.T., Luxon B.A., Brown K.E., Mathahs M.M., Bandyopadhyay S., McCaffrey A.P., Schmidt W.N. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?. Hepatology 2010, 52(6):1897-1905. http://www.ncbi.nlm.nih.gov/pubmed/21105106, 10.1002/hep.23921.
36. Lehmann E., El-Tantawy W.H., Ocker M., Bartenschlager R., Lohmann V., Hashemolhosseini S., Tiegs G., Sass G. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology 2010, 51(2):398-404. http://www.ncbi.nlm.nih.gov/pubmed/20044809, 10.1002/hep.23339.
37. Armstrong J.A., Hart P.D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. Journal of Experimental Medicine 1975, 142(1):1-16. http://www.ncbi.nlm.nih.gov/pubmed/807671, 10.1084/jem.142.1.1.
38. Armstrong J.A., Hart P.D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. Journal of Experimental Medicine 1971, 134(3 Pt 1):713-740. http://www.ncbi.nlm.nih.gov/pubmed/15776571, 10.1084/jem.134.3.713.
39. Frehel C., de Chastellier C., Lang T., Rastogi N. Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infection and Immunity 1986, 52(1):252-262. http://www.ncbi.nlm.nih.gov/pubmed/2870027.
40. Clemens D.L., Horwitz M.A. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. Journal of Experimental Medicine 1995, 181(1):257-270. http://www.ncbi.nlm.nih.gov/pubmed/7807006, 10.1084/jem.181.1.257.
41. Sanguinetti M., Ardito F., Fiscarelli E., La Sorda M., D'Argenio P., Ricciotti G., Fadda G. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. Journal of Clinical Microbiology 2001, 39(2):816-819. http://www.ncbi.nlm.nih.gov/pubmed/11158161, 10.1128/JCM.39.2.816-819.2001.
42. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. Journal of Experimental Medicine 2000, 192(7):1015-1025. http://www.ncbi.nlm.nih.gov/pubmed/11015442, 10.1084/jem.192.7.1015.
43. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine 2000, 6(4):422-428. http://www.ncbi.nlm.nih.gov/pubmed/10742149, 10.1038/74680.
44. Otterbein L.E., Choi A.M. Heme oxygenase: colors of defense against cellular stress. American Journal of Physiology - Lung Cellular and Molecular Physiology 2000, 279(6):L1029-L1037. http://www.ncbi.nlm.nih.gov/pubmed/11076792.
45. Epiphanio S., Mikolajczak S.A., Gonçalves L.A., Pamplona A., Portugal S., Albuquerque S., Goldberg M., Rebelo S., Anderson D.G., Akinc A., Vornlocher H.P., Kappe S.H., Soares M.P., Mota M.M. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe 2008, 3(5):331-338. http://www.ncbi.nlm.nih.gov/pubmed/18474360, 10.1016/j.chom.2008.04.003.
46. Silva-Gomes S., Appelberg R., Larsen R., Soares M.P., Gomes M.S. Heme catabolism by heme oxygenase-1 confers host resistance to mycobacterium infection. Infection and Immunity 2013, 81(7):2536-2545. http://www.ncbi.nlm.nih.gov/pubmed/23630967, 10.1128/IAI.00251-13.
47. Regev D., Surolia R., Karki S., Zolak J., Montes-Worboys A., Oliva O., Guroji P., Saini V., Steyn A.J., Agarwal A., Antony V.B. Heme oxygenase-1 promotes granuloma development and protects against dissemination of mycobacteria. Laboratory Investigation 2012, 92(11):1541-1552. http://www.ncbi.nlm.nih.gov/pubmed/22964851, 10.1038/labinvest.2012.125.
48. Jansen T., Daiber A. Direct antioxidant properties of bilirubin and biliverdin. Is there a role for biliverdin reductase?. Frontiers in Pharmacology 2012, 3:30. http://www.ncbi.nlm.nih.gov/pubmed/22438843, 10.3389/fphar.2012.00030.
49. Taillé C., El-Benna J., Lanone S., Dang M.C., Ogier-Denis E., Aubier M., Boczkowski J. Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. Journal of Biological Chemistry 2004, 279(27):28681-28688. http://www.ncbi.nlm.nih.gov/pubmed/15123630, 10.1074/jbc.M310661200.
50. Datla S.R., Dusting G.J., Mori T.A., Taylor C.J., Croft K.D., Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 2007, 50(4):636-642. http://www.ncbi.nlm.nih.gov/pubmed/17679649, 10.1161/HYPERTENSIONAHA.107.092296.
51. Manca C., Paul S., Barry C.E., Freedman V.H., Kaplan G. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infection and Immunity 1999, 67(1):74-79. http://www.ncbi.nlm.nih.gov/pubmed/9864198.
52. Taneja N.K., Dhingra S., Mittal A., Naresh M., Tyagi J.S. Mycobacterium tuberculosis transcriptional adaptation, growth arrest and dormancy phenotype development is triggered by vitamin C. PLOS One 2010, 5(5):e10860. http://www.ncbi.nlm.nih.gov/pubmed/20523728, 10.1371/journal.pone.0010860.
53. Vilchèze C., Hartman T., Weinrick B., Jacobs W.R. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nature Communications 2013, 4:1881. http://www.ncbi.nlm.nih.gov/pubmed/23695675, 10.1038/ncomms2898.
54. Oberley-Deegan R.E., Rebits B.W., Weaver M.R., Tollefson A.K., Bai X., McGibney M., Ovrutsky A.R., Chan E.D., Crapo J.D. An oxidative environment promotes growth of Mycobacterium abscessus. Free Radical Biology and Medicine 2010, 49(11):1666-1673. http://www.ncbi.nlm.nih.gov/pubmed/20807564, 10.1016/j.freeradbiomed.2010.08.026.
55. Oberley-Deegan R.E., Lee Y.M., Morey G.E., Cook D.M., Chan E.D., Crapo J.D. The antioxidant mimetic, MnTE-2-PyP, reduces intracellular growth of Mycobacterium abscessus. American Journal of Respiratory Cell and Molecular Biology 2009, 41(2):170-178. http://www.ncbi.nlm.nih.gov/pubmed/19097985, 10.1165/rcmb.2008-0138OC.
56. Fillebeen C., Rivas-Estilla A.M., Bisaillon M., Ponka P., Muckenthaler M., Hentze M.W., Koromilas A.E., Pantopoulos K. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C virus. Journal of Biological Chemistry 2005, 280(10):9049-9057. http://www.ncbi.nlm.nih.gov/pubmed/15637067, 10.1074/jbc.M412687200.
57. Lehmann E., El-Tantawy W.H., Ocker M., Bartenschlager R., Lohmann V., Hashemolhosseini S., Tiegs G., Sass G. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology 2010, 51(2):398-404. http://www.ncbi.nlm.nih.gov/pubmed/20044809, 10.1002/hep.23339.
58. Zhu Z., Wilson A.T., Luxon B.A., Brown K.E., Mathahs M.M., Bandyopadhyay S., McCaffrey A.P., Schmidt W.N. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?. Hepatology 2010, 52(6):1897-1905. http://www.ncbi.nlm.nih.gov/pubmed/21105106, 10.1002/hep.23921.
59. Gordon A.H., Hart P.D., Young M.R. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 1980, 286(5768):79-80. http://www.ncbi.nlm.nih.gov/pubmed/6993961, 10.1038/286079a0.
60. Malik Z.A., Iyer S.S., Kusner D.J. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. Journal of immunology 2001, 166(5):3392-3401. http://www.ncbi.nlm.nih.gov/pubmed/11207296, 10.4049/jimmunol.166.5.3392.
61. Hart P.D., Young M.R., Jordan M.M., Perkins W.J., Geisow M.J. Chemical inhibitors of phagosome-lysosome fusion in cultured macrophages also inhibit saltatory lysosomal movements. A combined microscopic and computer study. Journal of Experimental Medicine 1983, 158(2):477-492. http://www.ncbi.nlm.nih.gov/pubmed/6193224, 10.1084/jem.158.2.477.
62. Kelley V.A., Schorey J.S. Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron. Molecular Biology of the cell 2003, 14(8):3366-3377. http://www.ncbi.nlm.nih.gov/pubmed/12925769, 10.1091/mbc.E02-12-0780.